APLM
Apollomics Inc. Class A Ordinary Shares
NASDAQ: APLM · HEALTHCARE · BIOTECHNOLOGY
$13.08
+1.75% today
Updated 2026-04-29
Market cap
$28.71M
P/E ratio
—
P/S ratio
3.19x
EPS (TTM)
$-7.57
Dividend yield
—
52W range
$4 – $40
Volume
0.0M
WallStSmart proprietary scores
36
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A5.3
Quality
C+4.0
Profitability
C5.0
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$2.00
-84.70%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 380.80% QoQ
+ Debt/equity -0.17x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at -121.60%
- Negative free cash flow $-10.37M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $323000.00 | $821000.00 | $198000.00 | $8.50M | $8.99M |
| Net income | $-240.81M | $-172.60M | $-53.86M | $-10.94M | $-10.94M |
| EPS | — | — | — | — | $-7.57 |
| Free cash flow | $-43.19M | $-43.22M | $-28.77M | $-10.37M | $-10.37M |
| Profit margin | -74,554.49% | -21,023.26% | -27,201.01% | -128.69% | -121.60% |
Peer comparison
Smart narrative
Apollomics Inc. Class A Ordinary Shares trades at $13.08. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $8.99M. with profit margins at -121.60%.
Frequently asked questions
What is Apollomics Inc. Class A Ordinary Shares's stock price?
Apollomics Inc. Class A Ordinary Shares (APLM) trades at $13.08.
Is Apollomics Inc. Class A Ordinary Shares overvalued?
Smart Value Score 36/100 (Grade D, Sell).
What is the price target of Apollomics Inc. Class A Ordinary Shares (APLM)?
The analyst target price is $2.00, representing -84.7% downside from the current price of $13.08.
What is Apollomics Inc. Class A Ordinary Shares's revenue?
TTM revenue is $8.99M.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.19x
ROE-1,305.00%
Beta1.83
50D MA$17.22
200D MA$15.51
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—